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Abstract
Transcription factors drive organogenesis, from the initiation of cell fate decisions to the maintenance and implementation
of these decisions. The Drosophila embryonic salivary gland provides an excellent platform for unraveling the underlying
transcriptional networks of organ development because Drosophila is relatively unencumbered by significant genetic
redundancy. The highly conserved FoxA family transcription factors are essential for various aspects of organogenesis in all
animals that have been studied. Here, we explore the role of the single Drosophila FoxA protein Fork head (Fkh) in salivary
gland organogenesis using two genome-wide strategies. A large-scale in situ hybridization analysis reveals a major role for
Fkh in maintaining the salivary gland fate decision and controlling salivary gland physiological activity, in addition to its
previously known roles in morphogenesis and survival. The majority of salivary gland genes (59%) are affected by fkh loss,
mainly at later stages of salivary gland development. We show that global expression of Fkh cannot drive ectopic salivary
gland formation. Thus, unlike the worm FoxA protein PHA-4, Fkh does not function to specify cell fate. In addition, Fkh only
indirectly regulates many salivary gland genes, which is also distinct from the role of PHA-4 in organogenesis. Our
microarray analyses reveal unexpected roles for Fkh in blocking terminal differentiation and in endoreduplication in the
salivary gland and in other Fkh-expressing embryonic tissues. Overall, this study demonstrates an important role for Fkh in
determining how an organ preserves its identity throughout development and provides an alternative paradigm for how
FoxA proteins function in organogenesis.
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Introduction
The Fox family of winged helix DNA binding transcription
factors is quite large, with more than 40 known family members in
mammals and 18 in flies [1,2] (R.M. and D.J.A., unpubl.). The
mammalian proteins have wide-ranging activities from controlling
development and differentiation of dopaminergic neurons to
regulating the acquisition of vocal learning [2,3]. During develop-
ment, Fox family members regulate specialization of endothelial
cells, formation of the lymphatic vessels, and development of the
cardiac outflow tract [4]. Other Fox family members regulate
melanocyte differentiation, skin pigmentation, and the development
of specialized skin appendages, such as hair and nails [5,6]. Fox
proteins also play key roles in the immune system, regulating
thymus development, affecting immune suppression and autoim-
munity [7]. In addition, Fox proteins regulate such basic functions
as cell growth and proliferation, and contribute to both tumor
development and metastasis [8].
The FoxA1-3 proteins, originally known as hepatic nuclear
factors (HNF-3a, b and c), are among the best-studied members
of the Fox protein family [9]. FoxA proteins are required for
the development of the liver, lungs, pancreas and midbrain
dopaminergic neurons [3,10,11,12]. In several organs, including
those that derive from the gut endoderm, the foxA1 and foxA2
genes appear to have largely overlapping functions. The late
endodermal loss of each gene alone has very little affect, whereas
the simultaneous loss of both genes results in a complete failure of
internal organs, such as the liver, to form [9]. In other contexts,
FoxA function is not redundant. In addition to its overlapping
expression with foxA1 in the definitive endoderm and multiple
endodermal derivatives, foxA2 is expressed earlier in the node and
anterior primitive streak [13,14,15]. The complete knockout of
foxA2 results in the absence of the notochord, failure to form a gut
tube and defects in derivatives from multiple germ layers [16,17].
Unlike most other transcription factors, the FoxA1 protein has
been shown to bind and open chromatin, suggesting that it
functions as a ‘‘pioneer’’ protein providing target gene access for
other tissue-specific transcription factors [18]; recent studies,
however, showing FoxA1 also binds DNA in a relatively closed
chromatin conformation challenge this model [19].
Insight into the function and activities of the FoxA genes has
also come from studies of model organisms in which redundancy is
less of an issue; the worm C. elegans and the fruitfly D. melanogaster
each encode only a single FoxA homologue, PHA-4 and Fork
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expression profiles of worms containing extra pharyngeal cells to
those without pharyngeal cells, revealed a large number of
pharyngeal expressed genes with consensus binding sites for the
worm FoxA protein PHA-4 [23], which is essential for pharyngeal
development [20,21]. Analysis of several pharyngeal gene
enhancers suggested a model wherein PHA-4 directly activates
expression of most or even all pharyngeal-specific genes [23]. The
model further suggested that PHA-4 pharyngeal target genes with
high affinity binding sites are activated early when PHA-4
concentrations are low, whereas other targets with low affinity
binding sites are activated only at late stages when levels of PHA-4
are sufficiently high.
In flies, studies have focused on the role of the FoxA protein
Fork head (Fkh) in the embryonic and larval salivary gland (SG),
although as with the worm PHA-4 and mammalian FoxA genes,
Fkh is expressed in multiple embryonic cell types (Figure 1A). In
SGs, Fkh expression is activated by a homeotic protein, Sex
combs reduced (Scr), and two other cofactors, Extradenticle (Exd)
and Homothorax (Hth) (Figure 1B) [24,25]. Fkh plays many key
roles in the SG, including keeping the SG cells alive through
repression of the proapoptotic genes reaper and hid [26,27],
mediating the cell shape changes of SG invagination required to
form the SG tubes [27], and working with the SG-specific bHLH
protein Sage to regulate two downstream target genes, PH4aSG1
and PH4aSG2, which are required to maintain uniform patent
SG lumens [28] (Figure 1C). Fkh also regulates its own expression
and maintains expression of two other SG transcription factors,
CrebA and Sage [28,29,30]. In vitro binding studies reveal that
Fkh binds to the same consensus sites that have been described
for the vertebrate FoxA proteins and worm PHA-4, but that
certain residue combinations in key flanking positions disrupt
binding [31]. Studies of endogenous Fkh binding sites in vitro and
regulation of the corresponding target genes in vivo support these
findings [28], suggesting that the requirements for in vivo binding
and regulation by FoxA proteins may be relatively stringent.
Indeed, recent studies reveal that binding of both mammalian
FoxA and worm PHA-4 to consensus sites is similarly affected by
flanking sequences [32,33].
Although several key SG targets of Drosophila Fkh have been
analyzed to date, there have been no genome-wide surveys to
identify the range of Fkh targets. Here, we use two approaches to
obtain a more global view of Drosophila Fkh targets in both the SG
and the whole embryo. Our studies demonstrate that Fkh plays a
major role in SG maintenance and function. These studies also
reveal unexpected roles for Fkh in endoreduplication and in
blocking terminal gene expression in early embryos.
Results
Fkh plays a major role in maintaining salivary gland fate
and function
To determine what proportion of salivary gland (SG) genes
depend on Fkh for their expression, we performed a large-scale in
situ hybridization analysis of SG gene expression in WT and fkh
loss-of-function mutant embryos. SG genes were chosen from the
expression pattern database Release 2 of the Berkeley Drosophila
Genome Project (BDGP [http://www.fruitfly.org/cgi-bin/ex/
insitu.pl]), which is in the process of determining the embryonic
expression patterns of all Drosophila genes. Whole mount in situ
hybridization analysis of 190 different genes in WT embryos
revealed 127 with reliable SG expression. Of the 127 genes, 59%
(75 genes) had altered expression patterns in fkh mutants
(Figure 2A). Approximately half of the affected genes encode
Figure 1. Fkh plays a major role in salivary gland development.
(A) Fork head (Fkh) is expressed in the secretory cells of the salivary
gland (SG), anterior and posterior midgut primordia (AM and PM),
stomadeum (ST), Malpighian tubules (MT), a subset of neuroblasts (NB),
yolk nuclei (YN), hindgut (HG) and proventriculus (PV). (B) SG spec-
ification requires parasegment 2-expressed Sex combs reduced (Scr)
and two more widely-expressed cofactors, Extradenticle (Exd) and
Homothorax (Hth). Scr with Exd and Hth activate several early SG
transcription factors, including Huckebein (Hkb), Sage, Fkh, CrebA and
others. Expression of Scr and Hth and nuclear Exd localization disappear
during embryonic stage 11. Thus, Scr, Exd and Hth are not involved in
maintaining SG gene expression. Some early-expressed transcription
factors, such as Hkb, are also only transiently expressed in the SG.
(C) Three early expressed transcription factors, Sage, Fkh and CrebA,
continue to be expressed in the SG until early pupal stages when the
cells are histolyzed during metamorphosis. Maintained SG expression of
these genes requires Fkh, which directly regulates its own expression
and that of both CrebA and Sage. Fkh is required for SG invagination
and SG cell survival. Fkh and Sage control expression PH4aSG1 and
PH4aSG2, two genes required to maintain an open patent SG lumen.
CrebA elevates expression of secretory pathway component genes
(SPCGs) required for the high level secretory capacity of the SG.
doi:10.1371/journal.pone.0020901.g001
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PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20901Figure 2. In situ hybridization analysis reveals that Fkh affects expression of many salivary gland genes. (A) Fkh is required for normal
expression of 75 out of 127 tested SG genes. (B) Gene ontology (GO) terms associated with the SG Fkh downstream genes reveal that Fkh regulates
genes implicated in a variety of activities, including metabolism and secretion/ endocytosis. (C) SG genes can be categorized based on their temporal
patterns of expression. (D) Fkh affects the expression of fewer early genes than late genes. Expression of only 40% of early genes is affected by fkh
loss (left), whereas expression of 71% of continuously expressed genes (middle) and expression of 100% of late expressed genes are affected by fkh
loss (right). Importantly, most SG genes start to express during stage 10 or 11 (122/127), and the ‘upregulated later’ group and ‘only late expression
lost’ group are the largest groups of Fkh dependent genes in each category, indicating that Fkh regulates more SG genes in late stages.
doi:10.1371/journal.pone.0020901.g002
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e20901Figure 3. Six groups of fkh dependent genes. In situ hybridizations of examples from each group of SG genes is shown for WT and fkh mutants.
The fkh mutants are homozygous for Df(3L)H99, which blocks the SG cell death associated with fkh loss. Red arrowheads indicate the SGs. Blank
arrowheads indicate the salivary duct. (A,B) Lateral views of WT and fkh embryos at stage 11 are shown. (C–H) Left two panels show lateral views of
WT and fkh embryos at stage 11. Right two panels show ventral views of WT and fkh embryos at stage 13/14. SGs remain on the ventral surface of fkh
mutants. (A) Fkh does not affect expression of most early SG genes, including Noa36. (B) Expression of eight early SG genes was significantly reduced
in SGs of fkh mutants, as shown with CG32269. (C) Fourteen early genes affected by loss of fkh showed higher levels of expression in late embryonic
SGs. This group included trh and nyo, which are initially expressed throughout the SG and duct primordia but that subsequently become restricted to
the duct in WT embryos. (D) Two early expressed SG genes showed decreased expression at early stages and increased expression at late stages, as
shown for the Pepck gene. (E) Expression of 27% of continuously expressed SG genes was unaffected by fkh loss. The Hmu gene is an example of this
class. Hmu transcripts localize to the apical domains of SG cells. (F) 30% of continuously expressed SG genes showed reduced expression at all stages
in fkh mutants, as seen with CG30497. (G) Many continuously expressed genes were unaffected at early stages but showed reduced expression at late
stages, including the bHLH transcription factor gene sage. (H) All five late expressed SG genes were affected by loss of fkh, as observed with Mvl.
doi:10.1371/journal.pone.0020901.g003
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Ontology assignments: metabolism, secretion and endocytosis
(Figure 2B). Other genes affected by loss of fkh encode a variety of
proteins, suggesting that Fkh plays a major role in both SG
development and function.
Analysis of the temporal expression patterns of the SG genes in
WT and fkh mutants revealed that Fkh affects late gene expression
far more than it does early gene expression. SG genes were
grouped into three classes based on their WT expression pattern
(Figure 2C). ‘‘Early expressed genes’’ (59 genes) included those
expressed beginning at stage 10, when Fkh protein is initially
detected, and ending at around stage 13. ‘‘Continuously expressed
genes’’ (63 genes) were expressed beginning at stage 10 or 11 and
continuing through embryogenesis. The ‘‘late expressed genes’’ (5
genes) were expressed beginning after stage 12 and continuing
through embryogenesis. 73% (46/63 genes) of continuously
expressed genes and 100% (5/5 genes) of late expressed genes
were dependent on Fkh for their expression (Figure 2D), whereas
only 41% (24/59 genes) of early expressed SG genes were affected
by fkh loss (Figure 2D).
Further analysis revealed additional subtlety in how the early and
continuously expressed classes of genes were affected by fkh loss.
Early expressed genes affected by fkh loss could be classified into
three groups, ‘decreased’, ‘upregulated later’ and ‘decreased and
upregulated later’ (Figure 2D and 3A–D). Continuously expressed
Fkhdependentgenescould beclassifiedinto two groups,‘decreased’
and ‘only late expression lost’ (Figure 2D and 3E–G). All late
expressed genes were similarly affected by loss of fkh and showed
decreased expression (Figure 2D and 3H). The variety of expression
changes in fkh mutants suggests that Fkh can both activate and
repress gene expression and that SG genes are differentially
regulated between early and late stages of development.
The ‘decreased’ group of early expressed genes (eight genes)
includes those whose expression was significantly reduced or gone
in the SGs of fkh mutants (Figure 3B). These genes are good
candidates for direct regulation by fkh; moreover, their early
transient expression also suggests a potential role in SG
morphogenesis. The ‘upregulated later’ group of early expressed
genes (14 genes) showed no change in expression in SGs between
WT and fkh mutants at stage 11; however, expression persisted
much longer in fkh mutants than in WT (Figure 2D and 3C),
suggesting repression by Fkh at later stages. Interestingly, four
transcription factor-encoding genes are included in this group
(Figure 2B). One of these genes was trachealess (trh), which encodes
a bHLH-PAS transcription factor required for the development
of the salivary gland ducts [34]. As observed with other known
duct genes, trh is expressed initially in both the duct and secretory
gland primordia until stage 12 when Fkh downregulates its
expression in the secretory cells [34,35]. Another gene in the
‘upregulated later’ group, nyobe (nyo) [36] showed an expression
pattern similar to that of trh, although its expression persisted in
the proximal secretory cells in WT SGs to stage 13 (Figure 3C).
Two possibilities exist for regulation of nyo by Fkh: (1) like trh, nyo
could be repressed by Fkh in late secretory cells or (2) nyo
expression in duct cells could be activated by Trh and only
indirectly repressed by Fkh. The remaining genes in the
‘upregulated later’ group are not expressed in the duct or duct
primordia, suggesting that Fkh also represses late expression of a
subset of early secretory cell specific genes, including other
transcription factor genes. Expression of the ‘decreased and
upregulated later’ group of early SG genes (two genes) was
decreased or diminished at stage 11 but was also detected in SGs
of fkh mutants at stage 13, when expression of these genes in WT
SGs had disappeared (Figure 2D and 3D).
Figure 4. Fkh regulates some SG genes indirectly through
maintaining CrebA expression. (A) In situ hybridization of the baiser
gene in WT, fkh H99, CrebA mutants. As shown here with baiser, many
genes whose SG expression disappears only in late fkh mutants require
CrebA for their SG expression at all times. Red arrowheads: SGs. (B) Fkh
and CrebA bind different sites on SG polytene chromosomes,
suggesting that regulation of target genes does not involve cooperative
regulation by Fkh and CrebA. Red: aFkh, green: aCrebA, blue: DAPI.
doi:10.1371/journal.pone.0020901.g004
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genes in the ‘decreased’ group was either significantly decreased or
gone at all stages in fkh mutants (Figure 2D and 3F). These genes
are also good candidates for direct regulation by Fkh. Among this
group of targets is PH4aSG2, which encodes an ER enzyme whose
expression has been shown to be directly activated by Fkh [28].
The ‘only late expression lost’ group of continuously expressed
genes (27 genes) is likely to include both direct and indirect Fkh
targets (Figure 2D and 3G). An example of a direct target in this
group is CrebA, which encodes a bZip transcription factor required
for increased secretory capacity [29,37]. CrebA expression is
initially activated by the same transcription factors that activate
fkh expression in the SG - Scr, Exd and Hth. Both CrebA and Fkh
subsequently become directly dependent on Fkh for their
maintained expression, since expression of Scr, Exd and Hth
disappears early as the SG cells begin to invaginate [25,29,30].
Examples of likely indirect targets in the ‘only late expression lost’
group are 18 genes whose expression is also downregulated in
CrebA mutants, based on in situ and/or microarray analysis
[29,37]. Twelve CrebA target genes in the ‘only late expression
lost’ group have been categorized as being involved in secretion
and endocytosis based on Gene Ontology assignments, including
baiser (bai) (Figure 4A), which encodes a p24 protein family
member involved in ER-Golgi transport [38]( Table S1). Given
previous findings that Fkh directly maintains CrebA expression in
the SG [29] and that CrebA has been shown to directly regulate
expression of most secretory genes [37], Fkh may affect expression
of these genes only indirectly by maintaining CrebA expression.
Importantly, the secretory pathway genes that are also regulated
by CrebA represent a large proportion of the ‘only late expression
lost’ group.
Since the C.elegans Fkh/FoxA homolog PHA-4 is thought to
directly activate expression of most or perhaps all pharyngeal-
specific genes [23,39], we asked if CrebA and Fkh might cooperate
to directly maintain expression of their target genes in the SG.
Since both genes are normally expressed in the larval SG, we
simply stained larval SG polytene chromosomes with CrebA and
Fkh antibodies and asked if the two proteins bind an overlapping
set of sites. As shown in Figure 4B, there is very little overlap in the
sites bound by CrebA and Fkh, suggesting that Fkh plays no direct
role in the regulation of CrebA SG target genes.
In summary, our large scale in situ analysis reveals that Fkh
plays a major role in maintaining SG fate and physiological
activity. Fkh affects the majority of SG genes (59%) and loss of fkh
leads to both decreases and increases in SG gene expression. Our
analysis also identified a large number of new Fkh dependent
genes, which encode proteins implicated in a wide variety of
functions. Furthermore, we found that Fkh regulates the
expression of far more genes at late stages than at early stages.
This can be explained by a model wherein Fkh regulation of many
SG genes is indirect and through its role in maintaining the
expression of other SG transcription factors such as CrebA.
Fkh is not an ‘‘organ-specifying’’ gene
Our large scale in situ analysis revealed that Fkh affects the
expression of 59% of SG genes. In contrast, the hox protein Scr,
which functions upstream of Fkh, is required for expression of
every SG gene that has been tested [24,40,41,42]. Moreover, Scr
over-expression using a heat-shock inducible promoter results in
the formation of additional SGs in more anterior regions of the
embryo (parasegments 0 and 1) [43]. To ask if Fkh can also drive
formation of additional SGs, we expressed either Scr or Fkh
throughout embryos using UAS-Gal4 system [44]. Consistent with
previous findings [43], Scr expressed under the control of the
tubulin-Gal4 driver resulted in formation of extra SGs in the head
region (Figure 5E, F). Staining of these embryos with antibodies to
CrebA and Crb revealed that these extra SGs invaginated and
formed epithelial lumens. Transient CrebA expression without
Crb signal was also observed in all other embryonic segments at
early stages (Figure 5D,E). In contrast, Fkh expression driven by
the tubulin-Gal4 driver did not result in the formation of SGs in
additional segments (Figure 5G–I), even though CrebA was weakly
Figure 5. Fkh overexpression does not induce SGs in additional embryonic segments. Embryos were immunostained with aCrebA (Green)
and aCrb (red). (A–C) SGs form in only parasegment 2 (PS2) in wild type (not shown), tubulin(tub)-Gal4/+ (A–C) or UAS-fkh/+ (not shown) control
embryos (white arrowheads). (D–F) tub-Gal4 driven expression of UAS-Scr results in transient upregulated expression of CrebA in almost every
segment of the embryo (open arrowheads). Only the high-level CrebA expressing cells of parasegments 0 and 1 invaginate and make SGs (yellow
arrowheads) in addition to the endogenous glands in parasegment 2 (white arrowhead). (G–H) tub-Gal4 driven expression of UAS-fkh activates very
low-level expression of CrebA in almost all segments of the embryo but does not result in the formation of additional glands. High-level expression of
Fkh also disrupts invagination of the glands that normally form in PS2 (white arrowhead).
doi:10.1371/journal.pone.0020901.g005
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cells that expressed persistent high level CrebA were the salivary
duct primordia, consistent with the previously described role for
Fkh in shutting off duct specific gene expression [35]. Unexpect-
edly, fkh overexpression throughout the embryo arrested SG
development and disrupted germband retraction (Figure 5I).
These data reveal that, unlike Scr, Fkh is insufficient to drive SG
formation on its own.
Microarray studies of whole embryos reveal new roles for
Fkh
Our in situ hybridization analysis identified a large number of
Fkh-dependent SG genes; this analysis will have missed many Fkh
targets, however, since the BDGP expression datasets are
incomplete (only about 1/3 of the genome is represented so far)
and because the in situ hybridization analysis cannot identify genes
that might normally be repressed in the early SG by Fkh. Thus, to
identify additional fkh downstream target genes, we performed a
microarray analysis comparing the expression profiles of WT and
fkh stage 11 embryos. From the microarrays, we discovered 1102
down-regulated genes (with a fold change ,21.4, P,0.05) and
1087 up-regulated genes (with a fold change .1.4, P,0.05) in fkh
mutants compared to WT (Table S2). To validate the microarray
data, we selected a set of both down-regulated and up-regulated
genes from the microarray data and performed in situ hybridiza-
tion analysis of these genes in WT and fkh mutant embryos. Five of
the seven down-regulated genes we tested had notably reduced
expression and five of the nine upregulated genes we tested had
notably higher expression in fkh mutant embryos (examples are
shown in Figure 6A). These findings indicate that the microarray
approach can identify new Fkh dependent genes in the SG and
many additional cell types in which this transcription factor is
expressed.
To ask if the microarray approach was sensitive enough to
identify the SG genes we had previously shown to be regulated by
Fkh during stage 11, we asked if the Fkh dependent genes
identified by in situ analysis were included in the downregulated
set identified by microarray. Most of the 28 SG genes affected by
fkh loss at this stage did not show significant expression changes in
the microarray analysis; seven were downregulated, one was
upregulated and 20 were unchanged (Figure S1). This finding
suggests that genes that are expressed more broadly and but may
be regulated by Fkh in only the SG will be missed by this analysis,
which averages gene expression changes over the entire embryo
(see, for example, Fig. 3D; Figure S1).
To learn more about the types of genes regulated by Fkh in the
entire embryo, we analyzed the microarray data using DAVID
[45,46], a program that identifies functional groups (based on
Gene Ontology terms) that are enriched in a given dataset
compared with their representation in the entire genome. The
DAVID analysis revealed that genes involved in terminal
differentiation were significantly enriched in the upregulated data
set. Examples of these functional groups include chitin and
polysaccharide related genes (enrichment score: 6.74), cell junction
and synapse genes (enrichment score: 5.52), cuticle genes
(enrichment score: 4.90), extracellular matrix genes (enrichment
score: 4.04), and muscle genes (enrichment score: 3.48) (Figure 6B,
Table 1). These data suggest a general role for Fkh in repressing
expression of genes required for terminal differentiation in early
embryos.
DAVID analysis of the genes that were downregulated in fkh
mutants revealed a significant enrichment of chromosome and cell
cycle related genes (Figure 6C, Table 2). Examples of enriched
functional groups include DNA metabolic process (enrichment
score: 20.20), chromosome (enrichment score: 7.28) and cell cycle
(enrichment score: 3.30). These findings suggest an unexpected
role for Fkh in cell cycle progression. Only two of the top ten
enriched annotation clusters in the genes downregulated in fkh
mutants were not related to chromosomes and cell cycle. One
enriched cluster was linked to transcription (enrichment score:
3.44) and one was linked to lifespan (enrichment score 3.40).
Fkh is required for polytenization of embryonic tissues
The microarray data suggested a potential role for Fkh in
activating genes required for cell cycle progression. Interestingly,
most larval tissues cease normal mitotic divisions relatively early in
embryogenesis; larval cells grow by increases in cell size rather
than cell number. Indeed, by embryonic stage 11, only the larval
neuroblasts continue to proliferate. All other larval tissues,
including the SG, undergo the process of endoreduplication,
wherein the DNA replicates but the DNA strands do not separate.
This process leads to the formation of polytene chromosomes, a
well-known feature of the larval SGs. The large polytenized
chromosomes provide templates for the synthesis of RNAs and
corresponding proteins that are required in the larger larval cells.
The patterns of endoreduplication in embryos, which have been
determined by assaying BrdU encorporation [47], correspond
quite well with the pattern of Fkh expression; endoreduplication
occurs in the SG, anterior and posterior midgut (AMG and PMG),
hindgut (HG) and Malpighian tubules (MT), embryonic tissues
that express high levels of Fkh (Figure 1A). To ask if Fkh is
required for endoreduplication, we carried out BrdU labeling of
WT and fkh embryos, which marked not only the proliferating
CNS cells but also the endoreplicating cells of the SGs, midgut,
hindgut, and MTs in WT embryos (Figure 7A). In contrast, fkh
embryos showed BrdU encorporation only in the CNS revealing
that fkh is required for endoreplication (Figure 7A). To rule out
indirect effects through changes in cell fate, we stained WT and fkh
mutant embryos with the MT differentiation marker Cut [48].
The MTs of fkh mutants stained with Cut about half of the time
(Figure 7B) indicating that the failure of MTs to encorporate
BrdU, which occurs in 100% of fkh mutants, is not due to a change
in MT cell fate. Interestingly, the Cut staining also revealed
abnormal MT morphologies in fkh mutants, indicating a new role
for this FoxA protein (Figure 7B).
Since DNA content correlates with nuclear size, we also stained
embryos with a nuclear lamin antibody to outline the nuclear
membrane and with Pasilla antiserum [41] to mark SG nuclei, to
Figure 6. Microarray analysis suggests a role for Fkh in terminal differentiation and endoreplication. (A) Genes identified as both
downregulated and upregulated by microarray analysis show the expected expression changes in WT versus fkh mutant embryos when examined by
whole mount in situ hybridization. CG11275, CG7637 and dro5 all had notably reduced expression in fkh mutant embryos, whereas rpr expression was
notably higher in fkh mutants. The numbers indicate the fold-change of each gene. Red arrowheads: SGs. (B) Volcano plot shows genes whose
expression is significantly downregulated (blue filled circles) and upregulated (red filled circles) in fkh mutant embryos. Genes whose expression
changed but with P-values greater than 0.05 are shown with open circles. Highlighted in green are examples of upregulated genes in fkh mutants.
Chitin related: Cht3; cell junction and synapse: Syt4, Fas3, cora, and vari; cuticle: dy, Lcp65Ag3 and Cpr49Ac, ECM: Cg25C, vkg, mmy, and Mmp2; muscle:
mbl, Calcium: CalpA and TpnC41C. (C) The same volcano plot is shown in B with downregulated genes involved in chromosome metabolism and cell
cycle progression highlighted in green.
doi:10.1371/journal.pone.0020901.g006
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Annotation Cluster
a Gene Onotology (GO) term Fold enrichment P-value
1 (6.74) Chitin metabolic process 3.6 9.0610
29
Polysaccharide metabolic process 3.4 1.5610
210
Aminoglycan metabolic process 3.4 1.4610
29
Polysaccharide binding 3.0 9.2610
28
Pattern binding 3.0 9.2610
28
Chitin binding 3.0 2.7610
26
Chitin binding protein, peritrophin-A 2.9 1.5610
25
ChtBD2 2.6 6.8610
25
Carbohydrate binding 2.4 2.4610
26
Extracellular region 1.8 3.2610
27
2 (5.52) Synapse 3.8 8.3610
26
Cell junction 3.2 1.5610
25
Cell junction 3.0 9.8610
28
Synapse 2.9 1.0610
26
Synapse part 2.8 1.9610
25
3 (4.90) Structural constituent of cuticle 3.0 1.6610
27
Structural constituent of chitin-based larval cuticle 2.9 1.1610
22
Insect cuticle protein 2.8 4.4610
26
Structural constituent of chitin-based cuticle 2.8 4.4610
26
Structural molecule activity 1.8 9.1610
26
4 (4.04) Basement membrane 7.8 1.0610
24
Extracellular matrix part 7.2 1.8610
24
Extracellular matrix 4.0 4.2610
26
Proteinaceous extracellular matrix 4.0 1.0610
25
Extracellular region part 1.9 7.9610
23
5 (3.98) Fatty acid biosynthetic process 5.1 2.7610
25
Lipid synthesis 4.4 8.9610
23
Fatty acid metabolic process 4.1 9.2610
26
Organic acid biosynthetic process 3.6 2.1610
25
Carboxylic acid biosynthetic process 3.6 2.1610
25
Lipid biosynthetic process 2.3 1.3610
23
6 (3.60) Plasma membrane part 2.0 3.1610
28
Integral to plasma membrane 1.6 2.1610
22
Intrinsic to plasma membrane 1.6 2.5610
22
7 (3.48) Muscle 13 1.8610
25
Striated muscle thin filament 13 1.4610
24
Contractile fiber 10 3.3610
212
Sarcomere 9.8 1.0610
28
Contractile fiber part 9.7 3.1610
210
Muscle protein 9.4 2.4610
29
Myofibril 9.2 2.5610
28
Myofibril assembly 7.2 2.0610
24
Skeletal muscle tissue development 3.7 2.2610
23
Skeletal muscle organ development 3.3 4.2610
24
Striated muscle tissue development 3.3 5.3610
23
Striated muscle cell development 3.2 3.1610
23
Muscle cell development 3.2 3.1610
23
Muscle tissue development 3.2 6.2610
23
Striated muscle cell differentiation 3.1 4.1610
24
Muscle cell differentiation 2.9 4.6610
24
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were consistently smaller than those of their heterozygous (wild-
type) siblings (Figure 7C), in agreement with a failure of fkh mutant
SGs to undergo endoreduplication. Thus, the microarray data
have revealed a new role for fkh in endoreduplication, the process
required to create the polytenized chromosomes of larval tissues.
Discussion
In this work, we used genome-wide approaches to identify the
transcriptional targets of the Drosophila FoxA protein Fkh in the SG
and entire embryo. The in situ analysis revealed that Fkh plays a
major role in maintaining SG cell fate and affects expression of the
majority of SG genes (,59%). Through the detailed analysis of
expression changes, we learn that Fkh both upregulates and
downregulates SG gene expression and that regulation of many
SG target genes is indirect. We also show that Fkh is not sufficient
to drive SG development on its own, a finding consistent with a
role in maintaining but not specifying the SG fate. Our whole
embryo microarray experiments comparing transcripts from early
WT and fkh mutant embryos revealed two unexpected findings:
(1) that Fkh represses inappropriate expression of terminal
differentiation genes in early embryos and (2) that Fkh is required
for endoreduplication in the SGs and in other Fkh expressing
tissues.
Role of the FoxA proteins PHA-4 and Fkh in
organogenesis
The findings from our in situ analysis of fkh versus wild type SGs
suggest an alternative paradigm for how FoxA proteins regulate
organ-specific gene expression. There are profound differences in
how the fly FoxA protein Fkh regulates SG gene expression and
how the worm PHA-4 regulates pharyngeal gene expression;
however, there are some similarities. Both PHA-4 and Fkh
regulate many tissue-specific genes; PHA-4 regulates 100% of
pharyngeal genes and Fkh affects expression of the majority of SG
genes (59%). Both PHA-4 and Fkh regulate expression of other
transcription factors that contribute to tissue formation and/or
physiological activity. For example, both proteins activate
expression of bHLH proteins that work with them to activate
expression of tissue-specific downstream target genes; HLH-6 in
the case of PHA-4 [49,50] and Sage in the case of Fkh [28].
Finally, both FoxA proteins also repress expression of transcription
factors that are linked to alternative cell fates; PHA-4 represses
expression of the ectodermal regulator LIN-26 and Fkh represses
expression of Trachealess (Trh), a key factor in salivary duct
formation [34,51].
Our findings also reveal that PHA-4 and Fkh play different roles
in the two organs. Fkh plays a major role in maintaining and
implementing the SG cell fate. This role is critically important in
this organ since the factors that initiate the SG cell fate – Scr, Exd
and Hth – disappear shortly after the glands begin to form [25].
Fkh maintains cell fate, in large part, by maintaining its own
expression as well as the expression of at least two other SG-
specific transcription factors – CrebA and Sage. Fkh implements
the SG cell fate decision by regulating genes required for
morphogenesis and by collaborating with other tissue specific
factors, such as Sage, to activate SG specific enzymes and gene
products [28] (A. Vaishnavi et al., in prep.). Fkh is neither
necessary nor sufficient to specify the SG, whereas loss-of-function
and overexpression experiments suggest that PHA-4 is both
necessary and sufficient to specify, maintain and implement
Annotation Cluster
a Gene Onotology (GO) term Fold enrichment P-value
Actomyosin structure organization 2.7 4.4610
22
Actin cytoskeleton 2.3 4.6610
23
Muscle organ development 2.1 3.4610
23
8 (3.00) Domain: EF-hand 3 6.6 2.0610
25
Domain: EF-hand 4 6.1 1.8610
23
Domain: EF-hand 1 4.9 9.0610
25
Domain: EF-hand 2 4.9 9.0610
25
Calcium-binding region 1 4.8 7.8610
24
Calcium-binding region 2 4.8 7.8610
24
EF hand 4.8 1.6610
22
Signal transduction mechanisms / Cytoskeleton / Cell division
and chromosome partitioning / General function prediction only
3.3 1.5610
22
Calcium 2.4 1.9610
25
Calcium ion binding 2.3 4.1610
27
EF-Hand 1 2.1 3.2610
23
EF-Hand type 2.1 3.7610
23
Calcium-binding EF-hand 2.1 2.2610
22
EF hand 2.1 2.2610
22
EF-Hand 2 2.0 1.1610
22
EFh 1.8 4.5610
22
David analysis reveals a significant enrichment of eight annotation clusters (based on Gene Ontology terms) in the set of genes upregulated in stage 11 fkh mutant
embryos. Shown are all clusters with enrichment scores $3.00.
aThe enrichment score is shown in parentheses. P,0.05.
doi:10.1371/journal.pone.0020901.t001
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Annotation Cluster
a Gene Onotology (GO) term Fold enrichment P-value
1 (20.20) DNA repair 5.2 2.7610
220
Response to DNA damage stimulus 5.0 1.7610
221
DNA metabolic process 4.1 2.2610
227
Cellular response to stress 3.4 1.6610
214
2 (7.28) Chromosome 2.4 4.7610
211
Chromosomal part 2.4 6.3610
29
Intracellular non-membrane-bounded organelle 1.5 5.2610
26
Non-membrane-bounded organelle 1.5 5.2610
26
3 (5.23) Nuclear chromosome 3.4 1.7610
26
Nuclear chromosome part 3.4 5.2610
26
Nuclear chromatin 2.7 2.3610
22
Chromosomal part 2.4 6.3610
29
4 (4.34) DNA recombination 5.6 3.3610
29
Reciprocal meiotic recombination 3.6 1.0610
22
Meiosis I 3.0 2.7610
23
5 (3.77) Nucleoside binding 1.5 9.1610
26
ATP binding 1.5 9.7610
26
Adenyl ribonucleotide binding 1.5 1.1610
25
Adenyl nucleotide binding 1.5 1.3610
25
Purine nucleoside binding 1.5 1.7610
25
ATP-binding 1.5 3.4610
24
Purine nucleotide binding 1.4 2.1610
24
Ribonucleotide binding 1.4 2.6610
24
Purine ribonucleotide binding 1.4 2.6610
24
Nucleotide binding 1.3 5.0610
24
Nucleotide-binding 1.3 1.9610
22
6 (3.48) Double-strand break repair via homologous recombination 8.8 1.2610
23
Recombinational repair 8.8 1.2610
23
Double-strand break repair 7.1 1.5610
27
7 (3.44) DNA binding 1.8 7.5610
211
DNA binding 1.8 7.8610
26
Regulation of transcription from RNA polymerase II promoter 1.7 1.2610
22
Nucleus 1.6 6.1610
27
Transcription 1.6 9.0610
24
Transcription regulation 1.6 1.1610
23
Transcription 1.5 1.8610
23
Regulation of transcription 1.4 2.2610
24
Transcription regulator activity 1.3 1.4610
22
Regulation of RNA metabolic process 1.3 3.4610
22
Regulation of transcription, DNA-dependent 1.3 4.7610
22
8 (3.40) Aging 2.5 3.9610
24
Determination of adult life span 2.5 3.9610
24
Multicellular organismal aging 2.5 3.9610
24
9 (3.30) Female meiosis chromosome segregation 4.4 4.5610
25
Meiotic chromosome segregation 3.5 3.1610
25
Female meiosis 3.3 2.8610
25
Meiosis I 3.0 2.7610
23
Chromosome segregation 2.7 5.1610
26
Spindle organization 1.8 2.2610
23
M phase of meiotic cell cycle 1.8 2.8610
23
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100% of pharyngeal genes will be affected by loss of pha-4; similar
changes in SG gene expression are observed with the loss of Scr,
the hox gene that specifies the SG.
Finally and importantly, many of the genes affected at late stages
are likely to be only indirectly regulated by Fkh. This is certainly the
case for most, if not all, of the SG transcriptional targets of the
CrebA transcription factor, which mediates high-level secretory
capacity by upregulating genes encoding components of secretory
organelles[29,37].Evidenceforindirectregulationofthesegenesby
Fkh through CrebA includes the following: (1) Fkh is required only
for late expression of secretory genes, whereas CrebA is required at
all stages [29]. (2) Fkh is required to maintain but not initiate CrebA
expression in the SG [29]. (3) In vitro binding studies and in vivo
expression studies reveal that CrebA binding sites are required for
expression of secretory pathway genes [37]. (4) In the larval SG,
endogenous Fkh and CrebA bind to largely non-overlapping sites,
suggesting that binding of these factors is not interdependent and
that they do not work together to activate target genes (Figure 4B).
(5) Ectopic expression of CrebA alone is sufficient to induce high-
level secretory gene expression inmultipleother cell types, including
in the trachea, salivary duct, midline glia and ectodermal stripes,
tissues that do not express Fkh [37].
Discovering profound differences in both the role and mode of
action of FoxA proteins in these two simple models provides
alternative paradigms for considering how the mammalian proteins
function in the many cell types in which they are expressed and
required. Already, studies suggest that mammalian FoxA proteins
also function at multiple levels at various tissues. During midbrain
dopaminergic (mDA) neuron development, Foxa1 and Foxa2
activate the bHLH transcription factor Neurogenin 2, which is
required for cell fate specification [3]. The FoxA proteins are also
required for mDA differentiation and expression of a tyrosine
hydroxylase essential for dopamine production [3]. Similarly, FoxA
proteins activate early regulators of embryonic pancreatic develop-
ment, and function in mature b-cells to maintain glucose
homeostasis through regulation of insulin secretion [12,52].
Roles of Fkh in entire embryos
Although a comparison between the two large-scale approaches
to discovering target genes revealed that the in situ hybridization
analysis is a better way to find tissue-specific Fkh targets (for
example Fkh-dependent SG genes; Figure S1), the microarray
analysis uncovered some unexpected roles for Fkh. This whole-
genome, whole-embryo approach revealed that Fkh represses
expression of genes associated with terminal differentiation at early
embryonic stages and activates expression of genes associated with
cell cycle progression. Our studies following up on Fkh activation of
cell cycle genes revealed a new role for Fkh in endoreduplication,
the modified cell cycles that lead to formation of the giant polytene
chromosomes, the most well known of which are those from the
larval SG.
To our knowledge, Fkh is the first transcription factor to be
linked to endoreduplication in fly embryos. Indeed, the only other
factor known to affect this process in larval tissues is Sunspot (Ssp),
a zinc finger DNA binding protein that is negatively regulated by
Wingless signaling and that promotes endoreduplication in larval
salivary glands through activation of E2F-1 and PCNA expression
[53]. Based on our microarray data, expression of Ssp, E2F-1 and
PCNA are unaffected in fkh mutant embryos, suggesting that Fkh
affects this process through independent pathways (Table S2). The
Notch signaling pathway is required for endoreduplication in the
follicle cells of the ovary [54,55]. Interestingly, Notch is transiently
upregulated in SGs in stage 11 embryos [56], just prior to the first
Annotation Cluster
a Gene Onotology (GO) term Fold enrichment P-value
Meiosis 1.8 2.8610
23
Meiotic cell cycle 1.8 3.2610
23
Microtubule cytoskeleton organization 1.7 9.3610
24
Mitotic spindle organization 1.7 1.3610
22
Cell cycle 1.6 5.4610
25
Cell cycle process 1.6 5.7610
25
Cell cycle phase 1.6 3.0610
24
Microtubule-based process 1.6 1.6610
23
Mitotic cell cycle 1.6 1.8610
23
M phase 1.5 5.9610
24
Cytoskeleton organization 1.4 6.1610
23
10 (3.21) Non-recombinational repair 9.9 4.7610
23
Double-strand break repair via nonhomologous end joining 9.3 3.5610
22
Telomere capping 8.2 8.7610
23
Non-homologous end-joining 7.5 1.1610
22
Telomere maintenance 7.4 6.8610
26
Telomere organization 7.4 6.8610
26
Anatomical structure homeostasis 4.0 2.1610
25
Homeostatic process 2.0 1.3610
23
David analysis reveals a significant enrichment of ten annotation clusters (based on Gene Ontology terms) in the set of genes downregulated in stage 11 fkh mutant
embryos. Shown are all clusters with enrichment scores $3.00.
aThe enrichment score is shown in parentheses. P,0.05.
doi:10.1371/journal.pone.0020901.t002
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that one of the Notch ligands, Delta, is downregulated in fkh
mutants (Table S2). Thus, Fkh may work through Notch signaling
or in parallel to Notch to control endocycles. Since Fkh is
persistently expressed in this tissue, we favor a model in which Fkh
endows cells with the ability to undergo endocycles and other
signaling events determine when those cycles will occur. Perhaps
Wg or Notch signaling control the timing in all cells undergoing
endocycles. It will be exciting to learn if Fkh’s role in endor-
eduplication is conserved in other systems that undergo endor-
eduplication, including, for example, cancer cells.
Materials and Methods
Fly strains
The fly strains used in this study include Oregon R, fkh
6,
Df(3L)H99, CrebA
wR23, tub-Gal4, UAS-Scr (R.Mann) and UAS-fkh.
The UAS-fkh construct was generated by PCR amplification of the
fkh ORF from a cDNA clone using primers that introduced an
XhoI site at the 5’ end and an XbaI site at the 3’ end of the
amplified product. The amplified product was subsequently cloned
into XhoI/XbaI cut pUAST [44]. The UAS-fkh construct was
introduced into the genome by P-element mediated insertion, with
injection services provided by Rainbow Transgenics.
Large scale in situ hybridization analysis
Salivary gland genes for in situ analysis were chosen from the
expression pattern database Release 2 of the Berkeley Drosophila
Genome Project (BDGP). The corresponding cDNA clones were
obtained from collections maintained in the laboratories of Allan
Spradling or Phil Beachy or were purchased from the Drosophila
GenomeResourceCenter (DGCR). Digoxygenin-labelled antisense
RNA probes were generated and hybridizations were carried out
as described [57]. Df(3L)H99 fkh
6 homozygous embryos were
distinguished from their heterozygous siblings either morphologi-
cally or by the absence of lacZ hybridization, which is driven from a
Ubx-lacZ insert on the TM6B balancer chromosome. For some of
the early expressed genes, fkh
6 homozygous embryos were isolated
prior to hybridization using a COPAS Select embryo sorter (Union
Biometrica). Homozygous embryos were sorted based on the lack of
GFP signal driven by the Twi-GFP on TM3 balancer chromosome.
Immunohistochemistry
Embryo fixation and staining were performed as described [58].
The primary antibodies used were rabbit aFkh (1:1000, a gift from
S. Beckendorf), rat aCrebA (1:500)[59], mouse aCrb (1:10, Cq4,
DSHB), mouse ab-gal (1:10000, Promega), mouse aCut (1:50,
2B10, DSHB), rat aPS (1:500)[41], rat aBrdU (1:50, Serotec) and
mouse aLamin (1:100, ADL84.12, DSHB). The fluorescent-
secondary antibodies (Invitrogen) were used at a dilution of
1:500. Confocal images were obtained using an LSM510 Meta
confocal microscope (Carl Zeiss).
Polytene chromosome staining
Late third instar larval salivary gland polytene chromosomes
wereprepared as described [60], exceptthat the second fixationwas
Figure 7. Fkh is required for polytenization in the embryos. (A) The CNS cells of both WT and fkh H99 mutant embryos undergo normal
mitotic cycles throughout embryogenesis and encorporate BrdU. BrdU encorporation is also observed in cells that undergo endocycles in WT
embryos (The filled green arrowheads indicate SGs; open arrowheads indicate anterior and posterior midgut and the hindgut; the filled black
arrowhead indicates Malpighian tubules). BrdU encorporation is not observed in these tissues in fkh H99 mutant embryos. (B) Staining of WT and fkh
H99 mutant embryos with the Cut (Ct) antibody, which labels the Malpighian tubules (MTs), reveals that these cells are present in about half of the fkh
H99 mutant embryos, although fkh H99 mutants showed variable MT defects. Elongated MTs are visible in WT embryos stained with Ct antibodies
(left panel). MT staining is absent in some fkh H99 mutant embryos (middle panel). Other fkh mutants show variable defects in MT elongation (right
panel). (C) Staining of fkh H99 heterozygous SGs (two left panels) and fkh H99 homozygous mutant SGs (two right panels) with nuclear aLamin,
aPasilla (SG marker) and DAPI reveals that fkh H99 heterozygous SG nuclei are larger than fkh mutant SG nuclei, consistent with a failure of the fkh
mutant SGs to undergo normal endocycling. Bar: 10 mm.
doi:10.1371/journal.pone.0020901.g007
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rat aCrebA [59] were each used at a dilution of 1:100 and the
secondary fluorescent antibodies (Molecular Probes; Carlsbad, CA)
were used at a dilution of 1:200. Controls included staining WT SG
chromosomes with preimmune serum and/or staining with no
primary serum (when pre-immune serum was unavailable).
Microarray experiments to compare WT and fkh mutants
Total RNA was isolated from three independent collections of
stage 11 WT and three independent collections of stage 11 fkh
6
mutant embryos sorted by a COPAS Select embryo sorter (Union
Biometrica) as previously described [37], labeled, and hybridized
to the Drosophila genome 2.0 chip (Affymetrix). Following scanning,
intensity values were normalized (Partek Inc: Irizarry et al., 2003a,
2003b). Fkh dependent genes were identified based on a 1.4-fold
change in gene expression, with p-value ,0.05. This fold change
was selected because the change in gene expression is being
averaged over the entire embryo, which includes a majority of cells
that do not express Fkh. All of our microarray data are MIAME
compliant and have been deposited in the GEOarchive, accession
number GSE28324.
BrdU labeling
WT and Df(3L)H99 fkh
6 embryos were labeled with BrdU
following a modification of the protocol as described [47,61]. For
BrdU uptake, embryos were permeabilized by octane for 5 min,
and incubated in 1 mg/ml BrdU (Sigma-Aldrich) in Schneider’s
media (GIBCO) for 30 min at room temperature. Embryos were
subsequently fixed in a 1:1 mixture of 3.7% formaldehyde in PBS
and heptane for 30 min and devitellinized using methanol. For
optimal HRP detection, the labeled embryos were incubated in
2M HCl with 0.1% Tween 20 for 40 min and washed in 0.1M Na
Borate to stop the reaction. Immunohistochemistry to detect BrdU
was carried out as described above.
Supporting Information
Figure S1 Volcano plot of gene expression changes
between stage 11 WT and fkh mutant embryos. Genes
whose expression is significantly downregulated in fkh mutants are
shown with blue filled circles and genes whose expression is
sifnificantly upregulated in fkh mutants are shown with red filled
circles. Genes whose expression changed but with P-values greater
than 0.05 are shown with open circles. Highlighted in green are
Fkh-dependent SG genes identified by our in situ hybridization
analysis.
(TIF)
Table S1 Summary of the results from the large-scale in
situ hybridization analysis of SG genes in fkh mutants.
Column 1 indicates the CG assignment, column 2, the gene name
if one has been given, column 3, the cDNA used for the in situ
analysis, column 4, if expression changed or not, column 5, how
expression changed, if it did, column 5, gene function based on
Gene Ontology term assignments, and column 6, whether the
gene is known to be a CrebA target or not, based on the
microarray analysis [37].
(XLS)
Table S2 Fkh-dependent genes identified by the micro-
array analysis. Column 1 indicates the gene symbol or CG
assignment, column 2, the gene name or CG assignment, column
3, fold-change in expression (fkh vs WT), and column 4, p-value
(fkh vs WT) based on three independent samples of WT and three
independent samples of fkh mutant embryos.
(XLS)
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